In March 2020, Ozanimod (ZEPOSIA) received approval by FDA for the treatment of relapsing forms of Multiple Sclerosis (MS). MS is an autoimmune disease of the central nervous system that damages nerve cells and their connections in the brain and other parts of the body. This drug contains 5-phenyl-1,2,4-oxadiazole moiety in its backbone. We have made a set of Building Blocks, which contain such part – the perfect start for your research!